Jordan Armstrong outlines how adaptable DTP programs can reduce barriers and accelerate patient access to therapy. As ...
As global temperatures continue to rise and weather patterns grow more volatile, the pharmaceutical industry faces a mounting ...
Pharmaceutical manufacturers have historically relied on intermediaries—including pharmacy benefit managers (PBMs), ...
In today's Pharma Pulse, the FDA grants a 54-day fast-track approval for high-dose Wegovy under a new priority program while ...
Field Reimbursement Services at CoverMyMeds, explains how aligning hubs and reimbursement teams improves patient support.
Chronic shortages expose how low prices, fragile supply chains, and misaligned incentives are undermining the U.S. generic ...
Brok Vandersteen, VP of Business Development, AssistRX, explains how policy pressures push life sciences companies toward ...
In today's Pharma Pulse, the FDA approves Icotyde as the first targeted oral peptide therapy for moderate-to-severe plaque ...
Jordan Armstrong, VP of Business Development at AssistRX, explains how companies can tailor direct-to-patient strategies into ...
A $3 billion China investment targets localized oral solid-dose manufacturing and supply-chain redundancy to support ...
PharmaKonnect and co-founder of Tina’s Warriors, discusses the biggest post therapy launch patient support gaps.
In today’s Pharma Pulse, the FDA expands a key biologic approval for pediatric patients, and new research highlights the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results